April Conference at Purdue University Targets Antimicrobial Resistance

antimicrobial resistance conference header

Antimicrobial resistance (AMR) is a significant public health threat globally, and multi-drug resistant infections are predicted to only worsen over time (United Nations Foundation, 2021). Purdue University is taking a multidisciplinary approach to address this critical topic through a free conference to be held on the West Lafayette campus in April, with involvement by multiple Purdue colleges. 

In 2019, the US Centers for Disease Control and Prevention (CDC) reported that more than 2.8 million cases of antibiotic-resistant infections occur annually in the US, resulting in 35,000 deaths (CDC, 2019). Increased incidence of hypervirulent and multidrug resistant (MDR) bacterial pathogens has been attributed to the use, overuse, and misuse of antibiotics (FAO, 2016). However, AMR is a complex problem at the intersection of human, animal and environmental health (“One Health”) that can only be addressed through a multidisciplinary approach.

The upcoming Purdue University conference, scheduled for April 6 and 7 at the Stewart Center, is being organized by cross-disciplinary steering and advisory committees consisting of representatives from the colleges of Veterinary Medicine, Pharmacy, Science, Agriculture, and Engineering, and the departments of Comparative Pathobiology, Veterinary Clinical Sciences, Industrial and Physical Pharmacy, Agricultural and Biological Engineering, Animal Sciences, Food Science, and Biological Sciences.  The program will feature three segments, each covering an area related to AMR: Determinants, Dynamics, and Deterrence of Drug Resistance.

Each program segment will have a keynote speaker chosen based on their expertise in the specific area. After each keynote, three additional speakers from the Purdue faculty will present their research. Their talks then will lead into roundtable discussions during which participants will have the opportunity to deliberate about the information shared and its implications.

The conference also includes a poster competition with prizes being offered in three categories: Undergraduate Students, Graduate Students, and Professional Degree Students.  A poster Submission Intent Form must be submitted by February 28, 2023 to be entered in the competition.  Posters also are welcome from those not in one of the aforementioned categories.

“Purdue University is well-positioned to lead global efforts to combat antimicrobial resistance,” said Dr. Kenitra Hendrix, director of the Animal Disease Diagnostic Laboratory at the College of Veterinary Medicine and clinical associate professor of veterinary diagnostic microbiology, who is leading the interdisciplinary planning committee for the conference. “With excellence in animal agriculture, animal disease diagnostics, engineering, veterinary medicine and public health, processing and post-harvest food safety, and pharmacy and drug discovery, global AMR reduction could be Purdue’s next giant leap. The first step in this direction is creation of AMR-focused collaborations, which is a goal of this inaugural conference.”

The conference will kick-off with Dr. Gerry Wright, Distinguished University Professor in the Department of Biochemistry and Biomedical Sciences at McMaster University in Ontario, Canada. He will share his work related to determinants, or mechanisms, of AMR. Dr. Wright serves as executive director of Canada’s Global Nexus for Pandemics and Biological Threats and is a member of the Michael G. DeGroote Institute for Infectious Disease Research.  His talk will be followed by presentations from faculty in Medicinal Chemistry and Molecular Pharmacology, Biochemistry, and Agricultural and Biological Engineering.

In the next session, the dynamics of AMR will be addressed by Dr. Lance Price, a professor at George Washington University’s Milken Institute of Public Health in Washington D.C.  Dr. Price works at the interface between science and policy to address the growing crisis of antibiotic resistance.  His presentation will be followed by talks featuring faculty in Comparative Pathobiology and Animal Sciences.

The final session, dealing with deterrence of drug resistance, will be led by Dr. Jennifer Granick, associate professor of internal medicine in the Department of Veterinary Clinical Sciences at the University of Minnesota and a member of the university’s Antimicrobial Resistance and Stewardship Initiative Team.  Her talk on control and mitigation of AMR will be followed by presentations from faculty in Chemistry, Industrial and Physical Pharmacy and the Weldon School of Biomedical Engineering, and Comparative Pathobiology.

To learn more about the free conference and for access to links to sign-up for the poster contest as well as to register for the conference, click here.  Or, click here to go directly to the conference registration page.

Writer(s): Kevin Doerr | pvmnews@purdue.edu

Recent Stories

Purdue Veterinary Medicine’s Connection with Wildlife Rescue in Guatemala Highlighted during International Education Week

Hidden amid the dense forests near the shores of Lake Petén Itzá, the ARCAS Wildlife Rescue Center is one of Central America’s most active sanctuaries for endangered and trafficked wildlife. In addition to their conservation efforts, ARCAS (Asociación de Rescate y Conservación de Vida Silvestre) offers unparalleled hands-on experience for veterinary and biology students from around the world. The Purdue University College of Veterinary Medicine has proudly collaborated with ARCAS for many years, and International Education Week this week (November 16-22) provided the perfect opportunity to showcase this invaluable educational partnership.

Immersive Mixed Reality Experience Helps Purdue Veterinary Students Learn Cardiac Physiology

First year Doctor of Veterinary Medicine students at the Purdue University College of Veterinary Medicine recently stepped into a new era of learning — an immersive Mixed Reality (MR) experience at Purdue’s Envision Center. This cutting-edge session allowed students to interact with a dynamic, 3D representation of the heart, deepening their understanding of cardiac physiology in ways traditional methods cannot match.

Feathered Fame: Purdue Veterinary Medicine Research Featured on Journal Cover

The Department of Veterinary Clinical Sciences (VCS) at Purdue University is proud to announce that a recent study from its anesthesiology team has been selected as the cover feature for Veterinary Sciences (MDPI), Volume 12, Issue 11. Chosen from among 82 articles, the publication highlights the College of Veterinary Medicine’s growing impact in avian clinical research.

“Paws Up” – brought to you by the PVM Wellness Committee

Time to shine a spotlight on some “paws-itively” amazing work by one of our newest Purdue Veterinary Medicine staff members, Jennifer Hartman, VCS Curriculum Technologist in the Department of Veterinary Clinical Sciences.

“Paws Up” – brought to you by the PVM Wellness Committee

Today we are highlighting Rebecca Hoffman, BS, RVT, who is a veterinary technologist with the Bovine Field Service.

Learning Specialist Joins PVM Student Success Center Team

Purdue Veterinary Medicine’s Student Success Center is pleased to welcome Kelsey Luse Spille, who joined the team Monday, November 4, as a learning specialist.  In her new role, she will be supporting students with their academic needs while also serving as a member of the Veterinary Education Support Team (VEST), which assists faculty in developing inclusive teaching practices.

Purdue College of Veterinary Medicine Hosts Reception to Welcome New Dean Bret Marsh

Faculty, staff and students gathered at a reception in the Veterinary Medical Library Friday, November 8, to help extend a warm welcome the new dean of the Purdue University College of Veterinary Medicine, Dr. Bret Marsh.  The event marked the conclusion of the first week on the job for Dr. Marsh, who just started in the role Monday, November 4, after wrapping-up 30 years of service as Indiana State Veterinarian – the state’s top-ranking animal health leader.

Awareness Week to Shine Spotlight on Antimicrobial Resistance Next Week

Antimicrobial resistance (AMR) is a growing, significant One Health issue across the world. The WHO estimates that AMR was directly responsible for 1.27 million global deaths and contributed to 4.95 million deaths, with additional significant economic costs. AMR affects all countries and all income groups, and to tackle this urgent problem, researchers, producers, and practitioners from all areas must address the critical shortage of new antimicrobial drugs, and the use of antimicrobial drugs in medicine, farming, and industry. The week of November 18-24 is US Antibiotic Awareness Week and World AMR Awareness Week, and the College of Veterinary Medicine is taking advantage of these national and global campaigns to raise awareness about AMR and antimicrobial stewardship, and to highlight some of the research and practices being conducted at the college to address AMR.

PVM Faculty Honored for Research Success with Purdue Seed for Success Acorn Awards

When Purdue University’s Office of Research honored the accomplishments and innovative ideas of a host of researchers this week, several Purdue Veterinary Medicine scholars were among those recognized. At a ceremony Wednesday, November 14, in the Purdue Memorial Union North and South Ballrooms, the annual Seed for Success Acorn Awards were presented to Purdue Principal Investigators (PIs) and co-PIs who secured research awards of $1 million or more for a single proposal in fiscal year 2024.

Unlocking the Mysteries of the Brain

Despite more than six decades of research in the field of neuroscience, many functions of the brain — the most complex organ in the human body — remain a mystery. Recent research conducted in the Purdue University College of Veterinary Medicine and the Bindley Bioscience Center revealed that scientists are one step closer to understanding the process that activates and deactivates specific proteins within our cells. This breakthrough could one day lead to enhanced treatments that may slow down or perhaps reverse the advance of neurogenerative diseases such as Alzheimer’s, Parkinson’s and multiple sclerosis.